Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
Open accessThe DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.
Abstract
Although iron is essential in maintaining the function of the central nervous system, it is a potent source of reactive oxygen species. Excessive iron accumulation occurs in many neurodegenerative diseases including Alzheimer disease (AD), Parkinson's disease, and Creutzfeldt-Jakob disease, raising the possibility that oxidative stress is intimately involved in the neurodegenerative process. AD in particular is associated with accumulation of numerous markers of oxidative stress; moreover, oxidative stress has been shown to precede hallmark neuropathological lesions early in the disease process, and such lesions, once present, further accumulate iron, among other markers of oxidative stress. In this review, we discuss the role of iron in the progression of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is evidence that insoluble polymers (fibrillary tangles) of proteins such as the β-amyloid can bind iron (Castellani et al. 2007; Dickens and Franz 2010; Exley 2006; Good et al. 1992; Jiang et al. 2009; Mancino et al. 2009; Rival et al. 2009; Sayre et al. 2000b; Smith et al. 2007) and thereby act in an autocatalytic manner to promote further radical production and oxidative stress.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · cited 1×
“At the microscopic level, it has been demonstrated to accumulate in senile plaques in AD [30].”
BackgroundCherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“Suggested by the successful reports of metal chelation therapy for improving neuronal function and cell viability, redox-active iron is an attractive target for treatment of neurodegenerative disease [81, 82].”
BackgroundMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 1×
“On the other hand in situ hybridization and ultrastructural observations reveal that mitochondrial abnormalities exist in AD brain and many abnormal mitochondria are targeted to lysosomes [60].”
BackgroundSelf-citationIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355 · cited 1×
“Iron accumulation in AD has been shown to be particularly abundant in brain regions vulnerable to AD, including the hippocampal formation and association cerebral cortices [25].”
BackgroundSelf-citationHentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292 · cited 1×
“To maintain iron homeostasis, iron regulatory protein-1 and -2 (IRP1 and IRP2) regulate the expression of ferritin and transferrin receptor post-transcriptionally through iron response element (IRE) [16].”
BackgroundWidespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Self-citationHuang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · cited 2×
“Substitution of the histidine residue significantly decreases the aggregation by Fe [44].”
BackgroundSayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007 · cited 1×
“Although NFT possibly act as a redox center, we previously demonstrated that neurons, which lack NFT also contain oxidative modifications [21], suggesting that oxidative stress precedes the formation of NFT.”
BackgroundSelf-citationRitchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · cited 1×
“To date, treatment of AD with chelating agents such as desferroxamine and clioquinol, a Cu chelator, has been met with limited success [76, 77].”
BackgroundOxidative damage in Alzheimer's
Smith, M. A., Perry, G., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. (1996) · Nature · doi:10.1038/382120b0 · Cited by 894
Self-citationThe roles of iron in health and disease
Lieu, P. T., Heiskala, M., Peterson, P. A., & Yang, Y. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00006-6 · Cited by 804 · cited 1×
“Regarding iron storage, ferritin binds and stores intracellular iron in most CNS cells, keeping it in a redox-inactive state [14].”
BackgroundRNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease
Nunomura, A., Perry, G., Pappolla, M. A., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 722 · cited 1×
“Among the macromolecules modified by ROS, RNA is suggested as an early target of oxidative damage in AD brain [26].”
BackgroundSelf-citationAdvanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 714
Self-citationCurtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I., & Barnham, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100175200 · Cited by 649
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641 · cited 1×
“The three histidine residues of amyloid-b at position 6, 13, and 14 and one tyrosine residue at position 10, all located in the hydrophilic N-terminal part of the peptide [43, 44], behave as iron binding sites.”
BackgroundGenetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · cited 1×
“Suggested by the successful reports of metal chelation therapy for improving neuronal function and cell viability, redox-active iron is an attractive target for treatment of neurodegenerative disease [81, 82].”
BackgroundMagnetite biomineralization in the human brain.
Kirschvink, J. L., Kobayashi-Kirschvink, A., & Woodford, B. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7683 · Cited by 614
Sayre, L. M., Perry, G., Harris, P. L. R., Liu, Y., Schubert, K. A., & Smith, M. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740270.x · Cited by 540 · cited 1×
“The presence of redox metals in NFT has been shown to induce oxidative stress via H2O2 [57].”
BackgroundSelf-citationIncreased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., & Freedman, M. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6750 · Cited by 513
Effects of weak magnetic fields on free radical recombination reactions
Timmel, C. R., Till, U., Brocklehurst, B., Mclauchlan, K. A., & Hore, P. J. (1998) · Molecular Physics · doi:10.1080/00268979809483134 · Cited by 392
Redox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S., Chevion, M., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 375
Self-citationGabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373 · cited 1×
“Likewise, suppression of mitochondrial energy metabolism alters the processing of amyloid-b protein precursor to produce amyloidogenic derivatives [37, 38] such that several studies have shown that oxidative stress increases the production of amyloid-b [39–41], and that H2O2 affects increased intracellular [39, 42] an…”
BackgroundImmunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.
Pappolla, M. A., Omar, R. A., Kim, K. S., & Robakis, N. K. R. K. (1992) · PubMed · Cited by 365
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration
Bartzokis, G., Tishler, T. A., Lu, P. H., Villablanca, P., Altshuler, L. L., Carter, M., Huang, D., Edwards, N., & Mintz, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.005 · Cited by 341 · cited 1×
“relaxation rates as suggested several years ago [68, 74, 75].”
BackgroundMetal complexing agents as therapies for Alzheimer’s disease
Bush, A. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00120-3 · Cited by 310
Misonou, H., Morishima-Kawashima, M., & Ihara, Y. (2000) · Biochemistry · doi:10.1021/bi000169p · Cited by 304 · cited 1×
“Likewise, suppression of mitochondrial energy metabolism alters the processing of amyloid-b protein precursor to produce amyloidogenic derivatives [37, 38] such that several studies have shown that oxidative stress increases the production of amyloid-b [39–41], and that H2O2 affects increased intracellular [39, 42] an…”
BackgroundRibosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron
Honda, K., Smith, M. A., Zhu, X., Baus, D., Merrick, W. C., Tartakoff, A. M., Hattier, T., Harris, P. L., Siedlak, S. L., Fujioka, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500526200 · Cited by 280 · cited 1×
“In fact, studies show RNA oxidization is increased in AD brain [58] and subsequent protein translation is impaired [59].”
BackgroundSelf-citationShachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246 · cited 1×
“This is particularly important for the potential development of metal chelators as therapeutic agents [72, 73] and this information may also be exploited for non-invasive early detection of MRI 1642 Neurochem Res (2007) 32:1640–1645”
BackgroundMartins, R. N., Harper, C. G., Stokes, G. B., & Masters, C. L. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00615.x · Cited by 234
Copernicus revisited: amyloid beta in Alzheimer's disease
Josepha, J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00211-6 · Cited by 203 · cited 1×
“Targeting end-stage lesions likewise appears all the more naı̈ve as understanding of AD and its relationship with the aging process continues to improve [48, 50, 79, 80].”
BackgroundPatel, B. N., Dunn, R. J., & David, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4305 · Cited by 202 · cited 1×
“For the export of iron from neurons or non-neuronal cells, a brain-specific ceruloplasmin is suggested to play a role [10, 11].”
BackgroundStefanacci, L., SUZUKI, W. A., & Amaral, D. G. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961125)375:4<675::aid-cne8>3.0.co;2-z · Cited by 193 · cited 1×
“Iron uptake in the brain is tightly controlled by transferrin receptor in the endothelial cells and choroid plexus cells [7], or lactoferrin receptor on neurons [8, 9].”
BackgroundThe Identification and Characterization of Oxidized RNAs in Alzheimer's Disease
Shan, X., Tashiro, H., & Lin, C.-L. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04913.2003 · Cited by 185 · cited 1×
“In fact, studies show RNA oxidization is increased in AD brain [58] and subsequent protein translation is impaired [59].”
BackgroundFrederikse, P. H., Garland, D., Zigler, J. S., & Piatigorsky, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10169 · Cited by 184
LEE, H., CASADESUS, G., ZHU, X., TAKEDA, A., PERRY, G., & SMITH, M. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.001 · Cited by 179 · cited 1×
“Targeting end-stage lesions likewise appears all the more naı̈ve as understanding of AD and its relationship with the aging process continues to improve [48, 50, 79, 80].”
BackgroundSelf-citationPaola, D., Domenicotti, C., Nitti, M., Vitali, A., Borghi, R., Cottalasso, D., Zaccheo, D., Odetti, P. R., Strocchi, P., Marinari, U. M., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2164 · Cited by 177
Iron and iron management proteins in neurobiology
Connor, J. R., Menzies, S. L., Burdo, J. R., & Boyer, P. J. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(01)00303-4 · Cited by 173 · cited 1×
“Iron is involved in various cellular metabolisms, in particular, mitochondrial iron is incorporated into heme and cytochromes [17].”
BackgroundLactotransferrin immunocytochemistry in Alzheimer and normal human brain.
Kawamata, T., Tooyama, I., Yamada, T., Walker, D. G., & McGeer, P. L. (1993) · PubMed · Cited by 171
Nanoscale biogenic iron oxides and neurodegenerative disease
Dobson, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02386-9 · Cited by 170 · cited 1×
“relaxation rates as suggested several years ago [68, 74, 75].”
BackgroundSelf-citationIschemic stress induces deposition of amyloid ? immunoreactivity in human brain
Jendroska, K., Poewe, W., Pluess, J., Iwerssen-Schmidt, H., Paulsen, J., Barthel, S., Schelosky, L., Cerv�s-Navarro, J., Daniel, S. E., & DeArmond, S. J. (1995) · Acta Neuropathologica · doi:10.1007/bf00294806 · Cited by 163
Klomp, L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.12.1989 · Cited by 161 · cited 1×
“For the export of iron from neurons or non-neuronal cells, a brain-specific ceruloplasmin is suggested to play a role [10, 11].”
BackgroundNanoparticle and other metal chelation therapeutics in Alzheimer disease
Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 158 · cited 1×
“First, brain penetrant chelators are essential [78].”
Self-citationThe heme oxygenase system and its functions in the brain.
Maines, M. D. (2000) · PubMed · Cited by 157
Iron and transferrrin uptake by brain and cerebrospinal fluid in the rat
Crowe, A. P., & Morgan, E. H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91652-u · Cited by 152 · cited 1×
“The CNS uses its own transferrin whose expression is regulated by a CNS specific promoter [12, 13].”
BackgroundIn Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice
Jack, C. R., Wengenack, T. M., Reyes, D. A., Garwood, M., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., Holasek, S. S., Adriany, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2588-05.2005 · Cited by 148 · cited 1×
“relaxation rates as suggested several years ago [68, 74, 75].”
BackgroundPaola, D., Domenicotti, C., Nitti, M., Vitali, A., Borghi, R., Cottalasso, D., Zaccheo, D., Odetti, P. R., Strocchi, P., Marinari, U. M., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2756 · Cited by 146
Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue
Hautot, D., Pankhurst, Q. A., Khan, N., & Dobson, J. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rsbl.2003.0012 · Cited by 144 · cited 1×
“[67] reported elevated levels of biogenic magnetite in female AD subjects compared to both male and female controls.”
BackgroundSelf-citationNeuropathology of Alzheimer disease: pathognomonic but not pathogenic
Castellani, R. J., Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0071-y · Cited by 141 · cited 1×
“The problem with the lesion-centered approach is that the hallmark lesions of AD also occur in ‘‘normal aging,’’ and from the standpoint of the neuropathology of AD, such lesions are more likely a consequence of the disease process rather than a cause [2].”
BackgroundSelf-citationLeveugle, B., Spik, G., Perl, D. P., Bouras, C., Fillit, H. M., & Hof, P. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90202-x · Cited by 140 · cited 1×
“Iron uptake in the brain is tightly controlled by transferrin receptor in the endothelial cells and choroid plexus cells [7], or lactoferrin receptor on neurons [8, 9].”
BackgroundRouault, T. A. (2001) · Nature Genetics · doi:10.1038/91036 · Cited by 130
Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins
Double, K. L., Zecca, L., Costi, P., Mauer, M., Griesinger, C., Ito, S., Ben‐Shachar, D., Bringmann, G., Fariello, R. G., Riederer, P., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752583.x · Cited by 119 · cited 1×
“In the pars compacta region of the substantia nigra, neuromelanin is known to play a part in iron storage [15].”
BackgroundHall, E. D., Oostveen, J. A., Dunn, E., & Carter, D. B. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1062 · Cited by 113
Mattson, M. P., & Pedersen, W. A. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00082-3 · Cited by 105 · cited 1×
“Likewise, suppression of mitochondrial energy metabolism alters the processing of amyloid-b protein precursor to produce amyloidogenic derivatives [37, 38] such that several studies have shown that oxidative stress increases the production of amyloid-b [39–41], and that H2O2 affects increased intracellular [39, 42] an…”
BackgroundOlivieri, G., Hess, C., Savaskan, E., Ly, C., Meier, F., Baysang, G., Brockhaus, M., & Müller‐Spahn, F. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.310406.x · Cited by 105 · cited 1×
“Likewise, suppression of mitochondrial energy metabolism alters the processing of amyloid-b protein precursor to produce amyloidogenic derivatives [37, 38] such that several studies have shown that oxidative stress increases the production of amyloid-b [39–41], and that H2O2 affects increased intracellular [39, 42] an…”
BackgroundCalabrese, V., Scapagnini, G., Ravagna, A., Fariello, R. G., Stella, A. M. G., & Abraham, N. G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10177 · Cited by 103 · cited 1×
“For the regulation of heme metabolism, heme oxygenase plays an important role in the CNS [18, 19].”
BackgroundIn situ characterization and mapping of iron compounds in Alzheimer's disease tissue
Collingwood, J. F., Mikhaylova, A., Davidson, M., Batich, C., Streit, W. J., Terry, J., & Dobson, J. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7401 · Cited by 103 · cited 1×
“[62, 63] demonstrated the application of this technique to AD tissue sections.”
MethodSelf-citationMURAKAMI, N., YAMAKI, T., IWAMOTO, Y., SAKAKIBARA, T., KOBORI, N., FUSHIKI, S., & UEDA, S. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.993 · Cited by 100
Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?
McLachlan, D. R. C., Kruck, T. P. A., Lukiw, W. J., & Krishnan, S. (1991) · Europe PMC (PubMed Central) · Cited by 99
Gillis, S. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90098-r · Cited by 99
Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers
Roy, C. N. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2181 · Cited by 97
Dikalov, S. I., Vitek, M. P., Maples, K. R., & Mason, R. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9392 · Cited by 95
Vascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆
Shi, J., Perry, G. L., Smith, M. A., & Friedland, R. P. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00119-6 · Cited by 95
Self-citationMagnetic properties of human hippocampal tissue—Evaluation of artefact and contamination sources
Dobson, J., & Grassi, P. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02132-9 · Cited by 89
Self-citationSystemic iron metabolism: a review and implications for brain iron metabolism
Rouault, T. A. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(01)00260-0 · Cited by 89
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 87 · cited 1×
“Notably, the redox potential of iron is significantly attenuated by amyloid-b suggesting a neuroprotective chelating role for amyloid-b in disease pathogenesis [51, 52].”
BackgroundSelf-citationPerry, G. L., Nunomura, A., Raina, A. K., & Smith, M. A. (2000) · The Lancet · doi:10.1016/s0140-6736(05)72173-5 · Cited by 78
Self-citationInduction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells
Abe, K., George‐Hyslop, P. S., Tanzi, R. E., & Kogure, K. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90019-p · Cited by 77
TEM investigations of biogenic magnetite extracted from the human hippocampus
Schultheiss-Grassi, P. P., Wessiken, R., & Dobson, J. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00160-3 · Cited by 72
Arson: Tracking the Culprit in Alzheimer's Disease
SMITH, M. A., JOSEPH, J. A., & PERRY, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05557.x · Cited by 66
Self-citation(2015) · Rheumatology · doi:10.1093/rheumatology/kev158 · Cited by 62
Regulation of the Release of Interleukin‐6 from Human Astrocytoma Cells
Cadman, E. D., Witte, D. G., & Lee, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030980.x · Cited by 60 · cited 1×
“In fact, elevated levels of IL-1 and IL-6 in AD brain have been reported [56].”
BackgroundPerivascular astrocytes within Alzheimerʼs disease plaques
Cullen, K. M. (1997) · NeuroReport · doi:10.1097/00001756-199705260-00033 · Cited by 57
Magnetic Iron Compounds in Neurological Disorders
Dobson, J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.016 · Cited by 57
Self-citationThe cell cycle hypothesis of Alzheimer's disease: Suggestions for drug development
Woods, J., Snape, M., & Smith, M. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.004 · Cited by 54 · cited 1×
“A fundamental reorganization of the concepts related to etiology, pathogenesis, and treatment of AD seems warranted (e.g., [ 3 ]).”
BackgroundSelf-citationPredicting the failure of amyloid-β vaccine
Smith, M. A., Atwood, C., Joseph, J. A., & Perry, G. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08695-6 · Cited by 51
Self-citationFree radical formation in autopsy samples of Alzheimer and control cortex
Zhou, Y., Richardson, J. S., Mombourquette, M. J., & Weil, J. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11787-j · Cited by 47
Shi, J., Xiang, Y., & Simpkins, J. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00827-5 · Cited by 45
Therapeutic Opportunities in Alzheimer Disease: One for all or all for One?
Marlatt, M., Webber, K., Moreira, P., Lee, H.-G., Casadesus, G., Honda, K., Zhu, X., Perry, G., & Smith, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764644 · Cited by 43 · cited 1×
“, the result of the disease process rather than the cause [1].”
BackgroundSelf-citationMikhaylova, A., Davidson, M., Toastmann, H., Channell, J. E. T., Guyodo, Y., Batich, C. D., & Dobson, J. (2005) · Journal of The Royal Society Interface · doi:10.1098/rsif.2004.0011 · Cited by 41 · cited 1×
“The development of XAS as a technique for analyzing and mapping iron and other metals related to tissue structures in avian brain tissue was first reported in 2005 [61].”
MethodSelf-citationActivated microglia cause iron-dependent lipid peroxidation in the presence of ferritin
Yoshida, T., Tanaka, M., Sotomatsu, A., Hirai, S., & Okamoto, K. (1998) · NeuroReport · doi:10.1097/00001756-199806220-00003 · Cited by 40 · cited 1×
“Activated microglia also release iron from ferritin in a superoxide dependent fashion and result in lipid oxidation in vivo [55].”
BackgroundBowman, B. H., Jansen, L., Yang, F., Adrian, G. S., Zhao, M., Atherton, S. S., Buchanan, J. M., Greene, R., Walter, C., & Herbert, D. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12115 · Cited by 26 · cited 1×
“The CNS uses its own transferrin whose expression is regulated by a CNS specific promoter [12, 13].”
BackgroundDramatic Effect of Magnetite Particles on the Dynamics of Photogenerated Free Radicals
Scaiano, J. C., Monahan, S., & Renaud, J. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb01921.x · Cited by 25
Collingwood, J. F., Mikhaylova, A., Davidson, M. R., Batich, C. D., Streit, W. J., Eskin, T. A., Terry, J., Barrea, R. A., Underhill, R. S., & Dobson, J. (2005) · Journal of Physics Conference Series · doi:10.1088/1742-6596/17/1/009 · Cited by 20 · cited 1×
“[62, 63] demonstrated the application of this technique to AD tissue sections.”
MethodSelf-citation
Cited by
Magnetite pollution nanoparticles in the human brain
Maher, B. A., Ahmed, I. A. M., Karloukovski, V., MacLaren, D. A., Foulds, P. G., Allsop, D., Mann, D. M. A., Torres-Jardón, R., & Calderon-Garciduenas, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605941113 · Cited by 1,047
Hambright, W. S., Fonseca, R. S., Chen, L., Na, R., & Ran, Q. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.021 · Cited by 851
“Starting at 12 weeks after tamoxifen treatment, Gpx4BIKO mice exhibited significant deficits in spatial learning and memory function versus Control mice as determined by the Morris water maze task.”
MethodKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“Iron (and in some cases copper) is also strongly implicated in a variety of neurodegenerative diseases [867] [868] [869] [870] [871] [872] [836] [873] [837] [850] [874] [875] [876] [877] [854] [878] [879] [880] [881] [842] [882] [883] [884] [885] [886] [887] [888] [889] [890] [891] [892] [893] [894] [895] [896] [897]…”
Oxidative stress in Alzheimer disease: A possibility for prevention
Bonda, D. J., Wang, X., Perry, G., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 483
“For example, the excessive iron and copper deposits extensively reported in AD (Castellani et al., 2007; Sayre et al., 2000; Smith et al., 1994b, 2010) catalyze the formation of OH from H2O2 as well as the formation of advanced glycation end products (Castellani et al., 2001; Smith et al., 1994b).”
Self-citationFerroptosis and Its Role in Diverse Brain Diseases
Weiland, A., Wang, Y., Wu, W., Lan, X., Han, X., Li, Q., & Wang, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1403-3 · Cited by 467
Metadata
- Authors
- Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A., & Zhu, X.
- Affiliations
- University of Maryland, Baltimore (US)
- Centro de Neurociências e Biologia Celular (PT)
- University of Utah (US)
- Keele University (GB)
- The University of Texas at San Antonio (US)
- Case Western Reserve University (US)
- Corresponding author
- Smith, Mark A.
- ORCID
- Venue
- Neurochemical Research
- Published
- 2007-05-17
- Volume
- 32
- Issue
- 10
- Pages
- 1640-1645
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2091351161
- Cited by
- 180
- References
- 85
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 14 · 2020: 12 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 8 · 2015: 3 · 2014: 11 · 2013: 16 · 2012: 16
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Funders
- Alzheimer's Association
- Philip Morris International
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- iron, oxidative stress, Alzheimer's disease, reactive oxygen species, iron accumulation, neurodegeneration, Parkinson's disease, Creutzfeldt-Jakob disease, neurofibrillary tangles, amyloid plaques
- MeSH terms
- Alzheimer Disease, Animals, Biological Transport, Active, Humans, Iron, Oxidation-Reduction, Neurofibrillary Tangles, Oxidative Stress, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.